Absolute quantification of dystrophin protein in human muscle biopsies using parallel reaction monitoring (PRM)
Abstract
The need for a reliable and accurate method to quantify dystrophin proteins in human skeletal muscle biopsies has become crucial in order to assess the efficacy of dystrophin replacement therapies in Duchenne muscular dystrophy as well as to gain insight into the relationship between dystrophin levels and disease severity in Becker's muscular dystrophy. Current methods to measure dystrophin such as western blot and immunofluorescence, while straightforward and simple, lack precision and sometimes specificity. Here, we standardized a targeted mass spectrometry method to determine the absolute amount of dystrophin in ng/mg of muscle using full‐length 13C6–Arg– and 13C6,15N2–Lys–labeled dystrophin and parallel reaction monitoring (PRM). The method was found to be reproducible with a limit of quantification as low as 30 pg of dystrophin protein per mg of total muscle proteins. The method was then tested to measure levels of dystrophin in muscle biopsies from a healthy donor and from Duchenne and Becker's muscular dystrophy patients.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 08, 2019
- Source ID
- 10.1002/jms.4437
Entities
People
- Emily H. Canessa
- Eric Hoffman
- Mansi V. Goswami
- Tchilabalo Dilezitoko Alayi
- Yetrib Hathout
Organizations
- Binghamton University
- United States Department of Defense